Facebook
Twitter
LinkedIn
ForwardWhat's New in Vaccines
This session will review the key approaches to the development of a coronavirus vaccine and discuss key issues regarding PCV13, HPV, and Meningococcus Serogroup B vaccines.
UNLABELED USE DISCLOSURE
This activity will not include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), and the curriculum clearly indicates this fact.
PARTICIPATION AND CREDIT
Learners must register to participate in and receive credit for this online educational activity. Read the target audience, learning objectives, and author disclosures. Study the educational content online, answer the questions and complete the evaluation. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
CULTURAL/LINGUISTIC COMPETENCY
CAFP policy and California state law requires that each learning activity including a patient care element address the topic of cultural and linguistic competency. This activity meets this requirement.
Equitable and Inclusive Curriculum
CAFP requests all faculty to present content that uses inclusive language to guide care for all our diverse patients.
PRIVACY POLICY
The California Academy of Family Physicians (CAFP) is committed to protecting the privacy of its members and customers. CAFP maintains safeguards to store and secure information it has about members and customers. The safeguards may be physical, electronic or procedural. For more information, go to https://www.familydocs.org/privacy-policy/
QUESTIONS
For questions regarding the content of this activity or for technical assistance, contact cafp@familydocs.org.
The CAFP has made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education program does not imply endorsement by CAFP of any product or manufacturer identified.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
COPYRIGHT
© 2020 California Academy of Family Physicians. All rights reserved. No part of this activity may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.
Target Audience
This activity is designed for family medicine physicians and other primary care team members.
Learning Objectives
By the end of this session, participants should be able to:
- Discuss key issues in shared decision-making with patients regarding the PCV13, HPV, and Meningococcus Serogroup B vaccines.
- Describe the key approaches to developing a coronavirus vaccine, including potential benefits and risks of each approach.
GEORGE KENT, MD, MPH
Adjunct Clinical Professor
Stanford University, School of Medicine
Stanford, CA
George Kent, MD, completed his medical degree at Case Western Reserve University School of Medicine. He served his residency in Family Medicine at Community Hospital of Sonoma County in Santa Rosa, and also completed a Preventive Medicine residency at the Centers for Disease Control, where he served as a medical epidemiologist. Dr. Kent is a faculty physician with the Stanford-affiliated San Jose-O’Connor Family Medicine Residency Program, and is Clinical Professor at Stanford School of Medicine, Department of Medicine, Div. of Primary Care & Population Health. He practices full-scope Family Medicine, including OB, and is also a specialist in HIV Medicine. He has been active in medical education at the local, state, and national level throughout his 30-year career in Family Medicine. He also volunteers for international projects to provide medical care and to train health professionals in Latin America and Africa. Dr. Kent is a long-time member of CAFP and is a recipient of the Barbara Harris Award for educational excellence.
DISCLOSURE
George Kent, MD declares that in the past 12 months neither he nor his partner/spouse have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this continuing education activity.
CONFLICT OF INTEREST STATEMENTS
The California Academy of Family Physicians' (CAFP) Committee on Continuing Professional Development is responsible for identification, management and resolution of conflict for any individual who may have the potential to influence content, who have served as faculty, or who may produce CME/CPD content for the CAFP. Management/Resolution may include learner notification, peer review of content before presentation, requirement of EB-CME, changing topics, or even dismissing a potential planning or faculty member.
It is the policy of the CAFP to ensure independence, balance, objectivity, scientific rigor, and integrity in all their continuing education activities. All individuals with potential conflicts are contacted by CAFP staff or CCPD members, and issues of conflict have been discussed, managed, and resolved. All individuals with potential to influence the content of this program have submitted Conflict of Interest declarations that have been reviewed according to policy. All disclosures were made for work beginning January 1, 2020 and have been resubmitted and renewed annually. CAFP reviewed conflict of interest statements for each individual with potential to influence content and everyone in a position to influence content stated that neither he/she and/or his/her spouse/partner had any relevant financial interests to disclose.
0.50 AAFP PRESCRIBED
This Enduring Material activity, What’s New in Vaccines, has been reviewed and is acceptable for up to 0.50 Prescribed credits by the American Academy of Family Physicians. AAFP certification begins November 23, 2020. Term of approval is for one year from this date.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credits™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 0.50 AAFP Prescribed